Spectacular Progress in Lung Cancer Care.
Oncology (Williston Park)
; 35(1): 26-28, 2021 Jan 11.
Article
in English
| MEDLINE | ID: covidwho-1485807
ABSTRACT
Against the difficult and trying backdrop of the pandemic, cancer investigators persisted, and for patients with lung cancer, that persistence paid off in spectacular ways. With several new FDA approved treatments, as well as 2 new targetable mutations in non-small cell lung cancer (NSCLC), 2020 was a banner year in the overall lung cancer space. ONCOLOGY® recently sat down with Jennifer W. Carlisle, MD, of Emory University's Winship Cancer Institute, to discuss the many advances made during the last year for patients with lung cancer along with her hopes for further significant milestones in the year to come.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Lung Neoplasms
/
Medical Oncology
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Oncology (Williston Park)
Journal subject:
Neoplasms
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS